These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

191 related articles for article (PubMed ID: 31614217)

  • 1. Bronchodilator Dose Responsiveness in Children and Adolescents: Clinical Features and Association with Future Asthma Exacerbations.
    Grunwell JR; Nguyen KM; Bruce AC; Fitzpatrick AM
    J Allergy Clin Immunol Pract; 2020 Mar; 8(3):953-964. PubMed ID: 31614217
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Clinical significance of the bronchodilator response in children with severe asthma.
    Coverstone AM; Bacharier LB; Wilson BS; Fitzpatrick AM; Teague WG; Phipatanakul W; Wenzel SE; Gaston BM; Bleecker ER; Moore WC; Ramratnam S; Jarjour NN; Ly NP; Fahy JV; Mauger DT; Schechtman KB; Yin-DeClue H; Boomer JS; Castro M
    Pediatr Pulmonol; 2019 Nov; 54(11):1694-1703. PubMed ID: 31424170
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Bronchodilator responsiveness in children with asthma is not influenced by spacer device selection.
    D'Vaz N; Okitika TA; Shackleton C; Devadason SG; Hall GL
    Pediatr Pulmonol; 2019 May; 54(5):531-536. PubMed ID: 30719873
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Risk factors for fixed airflow obstruction in children and adolescents with asthma: 4-Year follow-up.
    Sousa AW; Barros Cabral AL; Arruda Martins M; Carvalho CRF
    Pediatr Pulmonol; 2020 Mar; 55(3):591-598. PubMed ID: 31909900
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Randomized trial of the addition of ipratropium bromide to albuterol and corticosteroid therapy in children hospitalized because of an acute asthma exacerbation.
    Goggin N; Macarthur C; Parkin PC
    Arch Pediatr Adolesc Med; 2001 Dec; 155(12):1329-34. PubMed ID: 11732951
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Airway reactivity is a determinant of bronchodilator responsiveness after methacholine-induced bronchoconstriction.
    Parker AL
    J Asthma; 2004 Sep; 41(6):671-7. PubMed ID: 15584317
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Serum eosinophil cationic protein levels and bronchodilator responses at acute asthma exacerbation.
    Lee MH; Lee JH; Park CH; Ahn YM; Koh YY
    Ann Allergy Asthma Immunol; 1997 Oct; 79(4):363-9. PubMed ID: 9357384
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Obesity and bronchodilator response in black and Hispanic children and adolescents with asthma.
    McGarry ME; Castellanos E; Thakur N; Oh SS; Eng C; Davis A; Meade K; LeNoir MA; Avila PC; Farber HJ; Serebrisky D; Brigino-Buenaventura E; Rodriguez-Cintron W; Kumar R; Bibbins-Domingo K; Thyne SM; Sen S; Rodriguez-Santana JR; Borrell LN; Burchard EG
    Chest; 2015 Jun; 147(6):1591-1598. PubMed ID: 25742612
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Forced expiratory volume in 1 second percentage improves the classification of severity among children with asthma.
    Fuhlbrigge AL; Weiss ST; Kuntz KM; Paltiel AD;
    Pediatrics; 2006 Aug; 118(2):e347-55. PubMed ID: 16864642
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Serum levels of soluble interleukin-2 receptor at acute asthma exacerbation: relationship with severity of exacerbation and bronchodilator response.
    Kim JT; Kim CK; Koh YY
    Int Arch Allergy Immunol; 1998 Dec; 117(4):263-9. PubMed ID: 9876228
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Inflammatory and Comorbid Features of Patients with Severe Asthma and Frequent Exacerbations.
    Denlinger LC; Phillips BR; Ramratnam S; Ross K; Bhakta NR; Cardet JC; Castro M; Peters SP; Phipatanakul W; Aujla S; Bacharier LB; Bleecker ER; Comhair SA; Coverstone A; DeBoer M; Erzurum SC; Fain SB; Fajt M; Fitzpatrick AM; Gaffin J; Gaston B; Hastie AT; Hawkins GA; Holguin F; Irani AM; Israel E; Levy BD; Ly N; Meyers DA; Moore WC; Myers R; Opina MT; Peters MC; Schiebler ML; Sorkness RL; Teague WG; Wenzel SE; Woodruff PG; Mauger DT; Fahy JV; Jarjour NN;
    Am J Respir Crit Care Med; 2017 Feb; 195(3):302-313. PubMed ID: 27556234
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Children with uncontrolled asthma and significant reversibility might show hypoxaemia.
    Taytard J; Lacin F; Nguyen TLT; Boizeau P; Alberti C; Beydon N
    Eur J Pediatr; 2020 Jun; 179(6):999-1005. PubMed ID: 32020332
    [TBL] [Abstract][Full Text] [Related]  

  • 13. A compendium and review of pediatric pulmonary function testing assessment opportunities for asthma.
    Hopp RJ; Wilson M; Pasha MA
    J Asthma; 2022 Aug; 59(8):1584-1589. PubMed ID: 34111364
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The CONCEPT trial: a 1-year, multicenter, randomized,double-blind, double-dummy comparison of a stable dosing regimen of salmeterol/fluticasone propionate with an adjustable maintenance dosing regimen of formoterol/budesonide in adults with persistent asthma.
    FitzGerald JM; Boulet LP; Follows RM
    Clin Ther; 2005 Apr; 27(4):393-406. PubMed ID: 15922813
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Bronchodilator responsiveness in wheezy infants and toddlers is not associated with asthma risk factors.
    Debley J; Stanojevic S; Filbrun AG; Subbarao P
    Pediatr Pulmonol; 2012 May; 47(5):421-8. PubMed ID: 22006677
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Augmentation of bronchodilator responsiveness by leukotriene modifiers in Puerto Rican and Mexican children.
    Tcheurekdjian H; Thyne SM; Williams LK; Via M; Rodriguez-Santana JR; Rodriguez-Cintron W; Avila PC; Burchard EG
    Ann Allergy Asthma Immunol; 2009 Jun; 102(6):510-7. PubMed ID: 19558011
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Maintenance asthma treatment with fluticasone/salmeterol combination via Diskus: effect on outcomes in inner-city children enrolled in TennCare.
    Nguyen WT; Stewart C; Fisher K; Tolley E; Lew DB; Self TH
    Allergy Asthma Proc; 2005; 26(2):129-34. PubMed ID: 15971472
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Recognition of asthma in adolescents and young adults: which objective measure is best?
    Ulrik CS; Postma DS; Backer V
    J Asthma; 2005 Sep; 42(7):549-54. PubMed ID: 16169787
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Clinical efficacy of racemic albuterol versus levalbuterol for the treatment of acute pediatric asthma.
    Qureshi F; Zaritsky A; Welch C; Meadows T; Burke BL
    Ann Emerg Med; 2005 Jul; 46(1):29-36. PubMed ID: 15988423
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Sustained bronchoprotection, bronchodilatation, and symptom control during regular formoterol use in asthma of moderate or greater severity. The Canadian FO/OD1 Study Group.
    FitzGerald JM; Chapman KR; Della Cioppa G; Stubbing D; Fairbarn MS; Till MD; Brambilla R
    J Allergy Clin Immunol; 1999 Mar; 103(3 Pt 1):427-35. PubMed ID: 10069876
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.